Kaempferol, a molecule with potential anti‐tumour activity, has been shown to modulate the expression of Ki67 in tumour tissues,58 suggesting that the observed alterations in Ki67 expression following EHH treatment in NSCLC could be attributed to kaempferol (Figure 13D). This evidence concerns the gene MKI67 and non-small cell lung carcinoma.